Copertina

Prevention and management of venous thrombosis in patients with cirrhosis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lara N. Roberts, Jecko Thachil
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Haematology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

In a nutshell: Testing DOAC levels—when, why and what it means?
di: Dawn Swan, et al.
Pubblicazione: (2026)

Prevention and management of indwelling catheter‐related thrombosis in sickle cell disease and thalassaemia: A British Society for Haematology Good Practice Paper
di: George Woodward, et al.
Pubblicazione: (2024)

Can machine learning identify inherited causes of thrombocytopenia? A feasibility study
di: Gerard Gurumurthy, et al.
Pubblicazione: (2026)

Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
di: Lara N. Roberts, et al.
Pubblicazione: (2024)

Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study
di: Nichola Cooper, et al.
Pubblicazione: (2024)

Service evaluation of R90 bleeding and platelet disorders gene panel in thrombocytopenia cases
di: G. Gurumurthy, et al.
Pubblicazione: (2024)

Challenging situations in patients with cancer‐associated thrombosis—Further clarification required in the British Society for Haematology guidelines—Response
di: Raza Alikhan, et al.
Pubblicazione: (2024)

Clonal haemopoiesis and venous thromboembolism risk
di: David P. Steensma
Pubblicazione: (2024)

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register‐based matched cohort study
di: Nurgul Batyrbekova, et al.
Pubblicazione: (2025)

Thromboembolic risk in superficial vein thrombosis involving the saphenopopliteal versus saphenofemoral junction
di: Crhistian‐Mario Oblitas, et al.
Pubblicazione: (2026)

PF4‐associated immune thrombocytopenia and thrombosis (PITT)—More than heparin and vaccines
di: Michael Makris
Pubblicazione: (2025)

Prevention and treatment of infection in patients with an absent or hypofunctional spleen: A British Society for Haematology guideline
di: Shamez N. Ladhani, et al.
Pubblicazione: (2024)

Anti‐PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT‐like and VITT‐like characteristics
di: Phillip L. R. Nicolson, et al.
Pubblicazione: (2025)

Efficacy and safety of romiplostim and eltrombopag in management of thrombocytopenia in Wiskott–Aldrich syndrome patients
di: Anna Ogneva, et al.
Pubblicazione: (2025)

Safety and efficacy of anti‐coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience
di: Vilmarie Rodriguez, et al.
Pubblicazione: (2026)

Clinical management of CMML—State of the art
di: K. Nachtkamp, et al.
Pubblicazione: (2025)

Evaluation of surgical evacuation of the uterus for abortion and management of miscarriage in patients with sickle cell disease: A multicentre UK study
di: Sonia Wolf, et al.
Pubblicazione: (2026)

British Society for Haematology updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children with haematological malignancies: A focus on patient safety
di: Y. L. Tracey Chan, et al.
Pubblicazione: (2025)

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper
di: Aisling Barrett, et al.
Pubblicazione: (2024)

Checkpoint inhibitors, obinutuzumab plus PET ‐adapted ultra‐low dose nodal radiotherapy yield high efficacy in treatment‐naïve follicular lymphoma: Results from the phase II ‘ FLUORO’ study
di: Arina Martynchyk, et al.
Pubblicazione: (2026)

Teclistamab for relapsed refractory multiple myeloma patients on dialysis
di: P. Lebreton, et al.
Pubblicazione: (2024)

Emergency department diagnosis and management of acute pulmonary embolism
di: Jesse O. Wrenn, et al.
Pubblicazione: (2024)

Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significance
di: Yazan Jabban, et al.
Pubblicazione: (2026)

The anticoagulated trauma patient in the wilderness
di: Emma P. DeLoughery, et al.
Pubblicazione: (2024)

Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
di: Tuan Hoang, et al.
Pubblicazione: (2025)

Comparability of external and internal control patients for the prospective randomized HOVON ‐103 trial in older AML patients
di: Sjoerd J. F. Hermans, et al.
Pubblicazione: (2025)

Pregnancy and childbirth in patients with Glanzmann Thrombasthenia
di: Amihai Rottenstreich, et al.
Pubblicazione: (2024)

Pseudothrombocytosis in a patient with severe burns
di: Stephanie Juané Kennedy
Pubblicazione: (2025)

Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations
di: Gayathri Ravi, et al.
Pubblicazione: (2024)

Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline
di: Anna L. Godfrey, et al.
Pubblicazione: (2025)

Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?
di: Clara Lo
Pubblicazione: (2024)

Thrombotic and bleeding complications in patients with AL amyloidosis
di: Despina Fotiou, et al.
Pubblicazione: (2024)

Management of vaccinations in patients with non‐Hodgkin lymphoma
di: Michele Merli, et al.
Pubblicazione: (2024)

Feasibility of plasma proteomics in patients with immune thrombocytopenia
di: Rick Kapur
Pubblicazione: (2024)

Hydrometrocolpos secondary to vaginal GVHD in an adolescent patient
di: Andrea Palasciano, et al.
Pubblicazione: (2025)

Melanonychia in polycythaemia vera patient treated with hydroxycarbamide
di: Marko Lucijanic, et al.
Pubblicazione: (2025)

Arsenic‐induced neurotoxicity in patients with acute promyelocytic leukaemia
di: Zoe Loh, et al.
Pubblicazione: (2024)

Prognostic stratification in DLBCL patients with aberrant MYC gene
di: Jian‐Rong Li, et al.
Pubblicazione: (2024)

Cognitive impairment among patients with chronic immune thrombocytopenia
di: David J. Kuter, et al.
Pubblicazione: (2024)

Impact of voxelotor discontinuation on patients with sickle cell disease
di: Jin Han, et al.
Pubblicazione: (2026)